IGF2BP2 and breast cancer: Since nucleotide sequence is thus insufficient to fully predict RBP-binding sites, we used large-scale motif-enrichment analysis of RNA-Seq data and experimentally validated RBP target sites from eCLIP data to identify circHIPK3–IGF2BP2 mRNA targets and regulatory tendencies that are consistent across ENCODE and BC cell lines.